Intelligent bio solutions inc. regains compliance with nasdaq listing requirement

New york, march 01, 2023 (globe newswire) -- intelligent bio solutions inc. ("intelligent bio solutions" or the "company") (nasdaq: inbs), a life sciences company developing and delivering intelligent, non-invasive, real-time testing solutions, today announced that on february 27, 2023, the company received a notification from the listing qualifications department of the nasdaq stock market llc ("nasdaq") informing the company that it has regained compliance with nasdaq listing rule 5450(a)(1) (the “minimum bid price requirement”).
INBS Ratings Summary
INBS Quant Ranking